Regarding bias. by Gee, J B
3 .. a--
Scientific Publications No. 90. Lyon:
International Agency for Research on Cancer,
1989;1-549
3. Spengler JD, Ozkaynak H, McCarthy JF, Lee
H. Summary ofsymposium on health aspects
of exposure to asbestos in buildings.
Cambridge, MA:Energy and Environmental
Policy Center, Harvard University, 1989.
4. WHO. Occupational exposure limit for
asbestos. Report No. 89.1. Geneva:World
Health Organization, 1989.
5. Bignon J, Saracci R, Touray JC, eds.
Biopersistence of respirable synthetic fibers
and minerals. IARC Scientific Publications
No. Lyon: International Agency for Research
on Cancer, 1992.
6. International Commission on Occupational
Health. Workshop on the health risks associ-
ated with chrysotile asbestos. Ann Occup Hyg
(in press).
7. Asbestos, carcinogenicity, and public policy
(letters). Science 248:797-802 (1990).
8. McDonald JC, McDonald AD. Asbestos and
carcinogenecity (letter). Science 249:844
(1989).
9. Langer AM, Nolan RP. Fibre type and bur-
den in parenchymal tissues of workers occu-
pationally exposed to asbestos in the United
States. In: Non-occupational exposure to
mineral fibre (Bignon J, Peto J, Saracci, R),
eds. IARC Scientific Publication No. 90.
Lyon: International Agency for Research on
Cancer, 1990;330-335.
10. Churg A, Wright JL, Vedal S. Fiber burden
and patterns of asbestos-related disease in
chrysotile miners and millers. Am Rev Respir
Dis 148:25-31(1993).
11. Browne K. A threshold for asbestos-related
lung cancer. Br J Ind Med 43:556-558
(1986).
12. Begin R, Masse S, Rola-Pleszczynski M,
Boctor M, Drapeau G. Asbestos exposure
dose-Broncho-alveolar milieu response in
asbestos workers and the sheep model: evi-
dences of a threshold for chrysotile-induced
fibrosis. In: Asbestos Toxicity (Fisher GL,
Gallo MA, eds). New York:Marcel Dekker,
1988;87-107.
13. Ilgren EB, Browne K. Asbestos-related
mesothelioma: evidence for a threshold in
animals and humans. Regul Toxicol
Pharmacol 13:116-132(1991).
14. Health Effects Institute. Asbestos in public
and commercial buildings: a literature review
and synthesis of current knowledge.
Cambridge, MA:Health Effects Institute,
1991;1-18.
15. Heintz NH, Janssen YM, Mossman BT.
Persistent induction of cfosand c-jun pro-
tooncogene expression by asbestos. Proc Natl
Acad Sci USA 90:3299-3303(1993).
16. Council on Scientific Affairs, American
Medical Association. Asbestos removal, health
hazards, and the EPA. J Am Med Assoc
255:696-697 (1991).
17. Whysner J, Kuschner M, Covello VT,
Rifkind AB, Rozman KK, Rosenkranz HS,
Trichopoulos D, Williams GM. Asbestos in
the air of public buildings: a public health
risk? Environmental Health and Safety
Council ofthe American Health Foundation.
Prev Med 23:119-125(1994).
18. Greenberg M, Schwartz B. Asbestos: is
removal best approach? Forum for Applied
Research and Public Policy, 1990;82-86.
19. Abelson PH. The asbestos removal fiasco.
Science 247:1017(1990).
20. Statement of Linda J. Fisher, Office ofToxic
Substances, EPA, before the Subcommittee
on Health and Safety of the Committee on
Education and Labor, US House of
Representatives, 13 April 1990.
The Question of Balance
In a recent editorial, "Media and Science:
Harmless Dioxin, Benign CFCs, and
Good Asbestos" (EHP 102:10), David P.
Rail decries the "mistakes in editorial poli-
cy and reporting" in science and medicine,
and suggests "balancing controversial views
in the same issue and to invite letters and
commentary for publication in the same
issue" of the journal in which the material
is published. He dealt with "serious envi-
ronmental concerns: dioxin, chlorofluoro-
carbons (CFCs), and asbestos."
In regard to the dioxin story in particu-
lar, Rail quoted from the Fingerhut (1)
report that "workers exposed to dioxin for
more than 2 years and observed for at least
20 years had a 46% greater cancer death
rate than expected." This article was
accompanied by an editorial which many
newspapers quoted at the time of the
report, and others did not, as Rail chose
not to. The editorial, written by Bailar (2),
notes that "Results are again equivocal.
Parties on both sides of the continuing
debate about the regulation ofdioxin expo-
sure will no doubt cite this work in sup-
port oftheir positions" (as I am doing, and
as Rail did, by not citing the editorial).
Bailar continues:
Some cancers were indeed more frequent in an
exposed group than among controls, but the differ-
ences were for the most part not statistically signifi-
cant, and the exceptions might be explained by a
combination of small, unavoidable biases in the
data and the multiple post hoc comparisons.
(Examine enough data at the usual 5 percent level
ofsignificance and about 1 time in 20 you will find
a statistically significant result where there is no
real effect.)
The information is there, but depend-
ing on the reporter, the newspaper, or the
scientist you will inevitably get a different
story. Following the Fingerhut article, for
example, one newspaper headline read
"Chronic Dioxin Exposure ups Cancer
Risk," another read "More Research into
Dioxin Urged," and still another "The
Deadliness of Dioxin Put in Doubt By
New Data."
Rail also states that "A 10-year follow-
up of those exposed to dioxin after the
chemical explosion at Seveso in 1976, pub-
lished in Epidemiology this summer,
showed an increase in some cancers"(3). I
believe Rail might have mentioned, for
completeness sake, that the report also
indicated that in one group of exposed
individuals, there was a decrease in breast
and uterine cancer, as was observed in a
very balanced news report from the New
York Times on 26 October 1993, by Keith
Schneider.
More recently, the article by Davis et
al. "Decreasing Cardiovascular Disease and
Increasing Cancer among Whites in the
United States from 1973 through 1987" in
the Journal of the American Medical
Association (4), was accompanied by an
editorial (5) which was in part critical of
the work, yet many media reports failed to
recognize the criticism of the editorial,
while others gave a very balanced report by
using both the article and the editorial (in
particular Jane Brody of the New York
Times, 16 February 1994).
These examples indicate that scientific
information is readily available, either in
the publication itself, or in the now com-
mon practice of the concurrent editorial
comment, and is more often critical ofthe
publication than not. Concurrent letters to
the editors are not necessary. Reporters, in
my opinion, have a good understanding of
what they read; it is what they choose to
report that may be faulted.
For the various media, the old saying
applies, namely good news is no news, bad
news is good news, except, ofcourse, ifyou
have a bias, and bias is not limited to
reporters. We scientists are full ofit, too.
Stephen S. Sternberg
Memorial Sloan-Kettering Cancer Center
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Regarding Bias
I was saddened to read Rall's editorial
comment on the paper in Science entitled
"Asbestos: Scientific Developments and
implications for Public Policy" (1). He
suggested the "industry association" of
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some ofthe authors needs to be explored. I
believe he would consider the late Irving
Selikoff to be a good friend. D'Agostino
and Wilson (2) wrote:
Each of these questions [about asbestos] has elicit-
ed heated disagreements, often including personal
attacks on motives and integrity. But as the best
known authority [Selikoffl on asbestos has stated:
"Arguments should be evaluated on their merits
and not by reference to the interests of those who
make them."
I agree with this, and to my knowledge
none of the authors of the Science paper
have, until this date, departed from this
policy. If now any one of us should, after
repeated similar aspersions, explode with
hurt or outrage, I for one would fully
understand. As for my own activities,
something ofthem is in the public domain
(3); they are neither hidden from editors
nor the subject for any apology.
J. Bernard L. Gee
Yale University School ofMedicine
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Response
In response to Mossman's comments, it is
clear that one form of asbestos or other is
somewhat more or less potent than other
forms. But given the complexities of the
many epidemiological studies and the vari-
ability of human response, it is impossible
to state much more than that. These differ-
ences are not likely to have much clinical
importance. The Health Effects Institute-
Asbestos Research (HEI-AR) report (1,2)
seems to agree. HEI-AR was an industry
government consortium that organized a
review of asbestos and the potential haz-
ards from asbestos in buildings. I quote
from section 6.2.2.5 (p. 6-34):
1. In cohorts ofpersons exposed occupational-
ly to elevated concentrations of airborne asbestos
fibers, the risks of lung cancer and mesothelioma
have been observed to increase with extent (level
and duration) ofexposure.
2. The data do not suffice to define the expo-
sure-risk relations precisely but are consistent with
conventional lung cancer increases in proportion to
the extent ofexposure to asbestos, and the increase
in absolute risk of mesothelioma caused by each
brief increment of exposure is proportional to the
extent ofthe additional exposure to the 2nd or 3rd
power oftime thereafter ...
5. Comparisons among the different cohorts
provide evidence that the risk of pleural mesothe-
lioma is appreciably higher with exposure to croci-
dolite than with exposure to chrysotile or amosite.
Peritoneal mesothelioma has almost always been
attributed to amosite orcrocidolite exposure.
6. The absence ofadequate exposure measure-
ments for the cohorts studied to data severely lim-
its the reliability of any quantitative risk assess-
ments that can be made at this time, especially
insofar as the risks oflow level exposure to fibers of
different sizes and types may be concerned.
7. Many ofthe groups ofasbestos workers that
have been studied epidemiologically were exposed
to more than one type ofasbestos, and the data on
risks caused by each separate variety are inadequate
and inconsistent. The panel therefore calculated
average risks for mixed exposures. These are appro-
priate for the purpose ofthis report, as some build-
ings contain more that one type ofasbestos.
(Item numbers 3 and 4 were excluded
because they deal with smoking and lung
cancer and mesothelioma.)
Thus the HEI-AR panel did not find
large differences between the types of
asbestos and found no evidence of a
threshold.
The HEI-AR panel found that the
data from in vivo and in vitro experimental
studies "are insufficient to indicate whether
there is a significant departure from linear-
ity" (p. 6-75).
Ilgren and Brown (3) are cited as show-
ing a threshold for asbestos: "Epide-
miological evidence of the type discussed
in this paper can never establish a negative
result, so final proof must rest with a
greater understanding of the underlying
biological mechanisms."
Kohyama and Suzuki (4) have found
many chrysotile fibers in mesotheliomas
and pleural plaques. Dement et al. (5) has
recently updated his South Carolina
cohort. About halfare alive, the standard-
ized mortality ratio for lung cancer is 2.24;
for all cancer it is 1.46, and two cases of
mesothelioma have been seen in this
cohort exposed to pure chrysotile. The
slope ofthe exposure-response relationship
was one of the highest seen for asbestos
exposed cohorts irrespective of fiber type
or industry (5). These reports make it clear
that chrysotile asbestos is a dangerous car-
cinogen and that no threshold has been
demonstrated.
The question of the abatement of
asbestos that is securely in place is not
technical. At some future time it, like most
man-made structures, will be disturbed. It
can be removed under precautions now or
it can be left so that some time in the
future, with or without proper precautions,
it will be disturbed.
In response to Sternberg's comments,
he should have additionally pointed out
that the decrease in breast cancer was not
statistically significant and the decrease in
uterine cancer was only one subgroup.
David P. Rail
Former Director, NIEHS
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